XML 58 R46.htm IDEA: XBRL DOCUMENT v3.5.0.2
Debt - Narrative (Details)
1 Months Ended 6 Months Ended 12 Months Ended
Jul. 01, 2016
conversion_right
d
$ / shares
Nov. 05, 2015
USD ($)
Apr. 01, 2015
conversion_right
d
$ / shares
Jan. 30, 2013
USD ($)
$ / shares
Jun. 30, 2014
USD ($)
shares
Aug. 31, 2013
USD ($)
conversion_right
shares
Jun. 30, 2016
USD ($)
institution
$ / shares
Jun. 30, 2015
USD ($)
Dec. 31, 2015
USD ($)
institution
shares
Aug. 31, 2015
USD ($)
Debt Instrument [Line Items]                    
Interest paid             $ 900,000 $ 1,724,000    
Gain (loss) on embedded derivative             4,700,000      
Credit line capacity             190,728,000      
Goodwill             $ 691,060,000   $ 743,348,000  
Number of financial institutions | institution             9   10  
Bio-Reference                    
Debt Instrument [Line Items]                    
Net assets             $ 1,000,000,000      
Goodwill             386,900,000     $ 386,858,000
Intangible assets             $ 513,900,000      
OPKO Health Europe                    
Debt Instrument [Line Items]                    
Weighted average interest rate             3.40%   4.30%  
Minimum | OPKO Health Europe                    
Debt Instrument [Line Items]                    
Variable interest rates             2.70%      
Maximum | OPKO Health Europe                    
Debt Instrument [Line Items]                    
Variable interest rates             6.30%      
Notes                    
Debt Instrument [Line Items]                    
Long-term debt             $ 45,233,000   $ 48,986,000  
Notes | Notes Due February 1, 2033                    
Debt Instrument [Line Items]                    
Debt face amount       $ 175,000,000.0            
Interest rate on notes payable       3.00%       3.00%    
Equivalent redemption price       100.00%            
Conversion Rate     0.1414827 0.1414827     0.1414827      
Conversion price per share (in dollars per share) | $ / shares     $ 7.07 $ 7.07     $ 7.07      
Convertible debt, threshold percentage of stock price trigger     130.00% 130.00%            
Number of consecutive trading days applicable conversion price     30 days              
Conversion right triggered | conversion_right     1     1        
2033 Senior Notes, conversion         $ 70,400,000 $ 16,900,000     $ 55,400,000  
Convertible debt, stock issued from conversion | shares           2,396,145        
Interest paid         $ 800,000          
Common stock trigger price (in dollars per share) | $ / shares     $ 9.19              
Number of trading days | d     20              
Long-term debt             $ 32,200,000      
Notes | Notes Due February 1, 2033 | Minimum                    
Debt Instrument [Line Items]                    
Number of trading days applicable conversion price       20 days            
Notes | Notes Due February 1, 2033 | Maximum                    
Debt Instrument [Line Items]                    
Number of consecutive trading days applicable conversion price       30 days            
Notes | Notes Due February 1, 2033 | On or after February 1, 2017 and before February 1, 2019                    
Debt Instrument [Line Items]                    
Equivalent redemption price       100.00%            
Line of Credit                    
Debt Instrument [Line Items]                    
Weighted average interest rate             4.60%   4.30%  
Common stock investments, available for sale | Notes | Notes Due February 1, 2033                    
Debt Instrument [Line Items]                    
Convertible debt, stock issued from conversion | shares         10,974,431       8,118,062  
Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Credit line capacity   $ 175,000,000.0                
Higher borrowing capacity option   $ 275,000,000.0                
Commitment fee percentage   0.25%                
Swingline | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Credit line capacity   $ 20,000,000.0                
Letter of Credit | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Credit line capacity   $ 20,000,000.0                
LIBOR | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate   2.50%                
LIBOR, First 12 Months | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate   0.35%                
LIBOR Thereafter | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate   0.50%                
LIBOR, First 12 Months, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate   1.35%                
LIBOR, Thereafter, Adjusted for Eurocurrency Liabilities | Revolving Credit Facility | Line of Credit | New Credit Agreement                    
Debt Instrument [Line Items]                    
Basis spread on variable rate   1.50%                
Subsequent Event | Notes | Notes Due February 1, 2033                    
Debt Instrument [Line Items]                    
Conversion Rate 0.1414827                  
Conversion price per share (in dollars per share) | $ / shares $ 7.07                  
Convertible debt, threshold percentage of stock price trigger 130.00%                  
Number of consecutive trading days applicable conversion price 30 days                  
Conversion right triggered | conversion_right 1                  
Common stock trigger price (in dollars per share) | $ / shares $ 9.19                  
Number of trading days | d 20